key: cord-0948844-avw4lc9n authors: Laiq, Simin; Al Yaqoobi, Mubarak; Al Saadi, Maimuna; Rizvi, Semee; Al Hajri, Zahra; Al Azri, Saleh; Al Ramadhani, Khalsa; Al Hinai, Qasim title: Fonsecaea associated cerebral phaeohyphomycosis in a post-COVID-19 patient: A first case report date: 2021-12-06 journal: Clin Infect Pract DOI: 10.1016/j.clinpr.2021.100126 sha: d4072e202de62bdda52bc3d6f842f9ec5ea90d35 doc_id: 948844 cord_uid: avw4lc9n Phaeohyphomycosis, previously known as chromoblastomycosis, is a chronic mycosis, usually affecting the skin. It is caused by dematiaceous fungi, which are a group of fungi that produce melanin in their cell walls. Cerebral phaeohyphomycosis occurs as a part of invasive presentation of the fungi, which usually affects immunocompromised patients, but may affect immunocompetent individuals as well. Cerebral infection in phaeohyphomycosis is associated with a poor prognosis regardless of the immune status of the patient. COVID-19 SARS-CoV-2 infection and/or medications used for its treatment may compromise the immune system, including in the post-COVID-19 period, resulting in invasive fungal infections, which have frequently been reported recently during the COVID-19 pandemic. We report a case of Fonsecaea associated cerebral phaeohyphomycosis in a recently diagnosed diabetic Omani lady, who presented to our hospital 6 weeks after recovery and discharge from hospitalization for moderate COVID-19 pneumonia. prior to presenting at our hospital). She was also diagnosed to have COVID-19 infection, 9 weeks 59 prior to presentation at our hospital. She had no other known immunodeficiencies and testing for 60 HIV-1 and HIV-2 antigens and antibodies was negative. During her COVID-19 infection, she developed COVID-19 pneumonia, which was mild initially, 62 and treated with oral antibiotics and steroids (dexamethasone 6 mg/OD) at home, but later the 63 pneumonia became severe enough to require 4-day hospitalization and oxygen support via high 64 flow nasal cannula. In-hospital, she received steroids (intravenous dexamethasone (6mg/OD)) and 65 antibiotic treatment (cefuroxime followed by ceftriaxone) for suspected superadded bacterial 66 infection. Prior to admission for COVID-19 she was on oral hypoglycemics for control of her 67 diabetes, but during her hospital stay, her blood glucose became uncontrolled, for which she 68 required insulin injections. She was discharged from hospital on day-18 of COVID-19 infection, 69 with a prescription for insulin for diabetes. She then presented to our hospital 6 weeks after discharge for her COVID-19 pneumonia. On 71 examination, she was confused, not oriented and Glasgow coma scale was 14/15 (E4M6V4). Motor examination was unremarkable and gait examination was difficult to assess due to her 73 confusion. COVID-19 testing by PCR, on day of admission was negative. Her glycated 74 hemoglobin (HbA1c) was 9.95% (reference range 4.4 -6.4%). Brain imaging showed a rim 75 enhancing lesion in the left parieto-occipital region with surrounding vasogenic edema (Figure 1 ). The differential diagnoses of brain abscess and tumor were considered. She was given intravenous 77 dexamethasone to reduce brain edema. She later underwent a left-parieto-occipital craniotomy and Fungal infections of the central nervous system Epidemiology of central nervous system mycoses Medically Important Fungi: A Guide to Identification Primary central nervous system phaeohyphomycosis: 154 a review of 101 cases World Health Organization. Statement on the second meeting of the International Health 156 Emergency Committee regarding the outbreak of novel coronavirus (2019-157 nCoV) World Health Organization. WHO Director-General's opening remarks at the media briefing 162 on COVID-19 -11 Post COVID-19 Mucormycosis -from the Frying Pan into the Fire Revisiting rhino-orbito-168 cerebral acute invasive fungal sinusitis in the era of COVID-19: pictorial review Cladophialophora bantiana: a rare cause of 172 fungal brain abscess. Clinical aspects and new therapeutic options Epidemiology, clinical manifestations, and therapy of infections 175 caused by dematiaceous fungi Molecular diversity of Fonsecaea (Chaetothyriales) causing 180 chromoblastomycosis in southern China Fonsecaea pugnacius, a Novel Agent of 183 Disseminated Chromoblastomycosis Draft Genome Sequence of Fonsecaea nubica Strain 186 CBS 269.64, Causative Agent of Human Chromoblastomycosis Cerebral phaeohyphomycosis by Fonsecaea monophora: 189 Report in a patient with AIDS and a ring enhancing lesion Diabetes and COVID-19: The 192 past, the present, and the future On DWI not shown, 207 the lesion is intensely bright peripherally with corresponding very dark signal on ADC map (A) 208 (red-white arrow) consistent with significant diffusion restriction. On T2 (B), the lesion 209 demonstrates heterogenous signal intensity with hyperintensity centrally and intermediate signal 210 peripherally with evidence of dark peripheral rim (red-white arrow) and surrounding vasogenic 211 edema (red-white star) B) Brain abscess with mixed inflammatory cell 218 infiltrate (consisting of neutrophils, lymphocytes, plasma cells and histiocytes), reactive 219 astrocytes, and numerous pigmented brown septate branching fungal hyphae Eosin stain, magnification 40X, (B) Hematoxylin & Eosin stain, magnification 100X, oil) Special stains highlight the numerous septate branching fungal hyphae (C) Periodic 222 acid-Schiff (PAS) stain, magnification 10X, (D) Periodic acid-Schiff (PAS) stain, magnification 223 40X, (E) Periodic acid-Schiff (PAS) stain, magnification 100X, oil, (F) Grocott's methenamine 224 silver (GMS) stain, magnification 10X, (G) Grocott's methenamine silver (GMS) stain, 225 magnification 40X A) Chocolate agar and (B) Sabouraud dextrose agar plates showing greyish-black 234 fungal colonies. (C, D) Microscopically, septate, loosely branching fungal hyphae with 'budding' 235 growth of conidiophores and conidia fruiting structure were observed ((C) Periodic acid-Schiff 236 stain, magnification 100X, oil, (D) Papanicolaou stain, magnification 100X, oil) B) Brain abscess with mixed inflammatory cell 256 infiltrate (consisting of neutrophils, lymphocytes, plasma cells and histiocytes), reactive 257 astrocytes, and numerous pigmented brown septate branching fungal hyphae Eosin stain, magnification 40X, (B) Hematoxylin & Eosin stain, magnification 100X, oil) Special stains highlight the numerous septate branching fungal hyphae (C) Periodic acid-260 PAS) stain, magnification 40X, (D) Periodic acid-Schiff (PAS) stain, magnification 100X